Joseph Salfity, MD
Vascular Surgery · Raleigh, NCNPI 1881984656
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (51.1%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 38 manufacturers reported payments, led by Silk Road Medical, Inc. at 26.4% of the total. 2025 is the largest year on record at $2,933, 2.7 times the $1,089 reported in 2019.
Across 144 payments — averaging $87.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Silk Road Medical, Inc.$3K
- Boston Scientific$3K
- Penumbra, Inc.$2K
- Bard Peripheral Vascular, Inc.$1K
- W. L. Gore & Associates, Inc.$842
- Medtronic$494
- plus $2K from 32 others
What the payments were for
- Consulting fees$2,10017%
- Travel & lodging$4,02432%
- Food & beverage$6,40551%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Silk Road Medical, Inc. | 16 | $3,310 |
| Boston Scientific | 28 | $2,818 |
| Penumbra, Inc. | 9 | $2,166 |
| Bard Peripheral Vascular, Inc. | 6 | $1,049 |
| W. L. Gore & Associates, Inc. | 14 | $842 |
| Medtronic(2 entities) | 15 | $494 |
| Stryker | 1 | $390 |
| Shockwave Medical, Inc | 2 | $165 |
| Bolton Medical Inc | 3 | $134 |
| Lemaitre Vascular, Inc. | 5 | $115 |
| Kerecis Limited | 1 | $110 |
| Johnson & Johnson | 6 | $105 |
| Abbott | 4 | $94 |
| Polarityte, Inc. | 2 | $90 |
| Smith+Nephew | 4 | $82 |
| Cook Medical LLC | 3 | $52 |
| Pfizer | 2 | $48 |
| Baxter Healthcare | 2 | $44 |
| Endologix LLC | 1 | $40 |
| Terumo Medical Corporation | 2 | $38 |
| Solventum Corporation | 1 | $35 |
| Walk Vascular, LLC | 1 | $33 |
| Acell, Inc. | 1 | $23 |
| Avita Medical Americas, LLC | 1 | $22 |
| Philips North America LLC | 1 | $22 |
| Osiris Therapeutics Inc. | 1 | $20 |
| Davol Inc. | 1 | $20 |
| Irhythm Technologies, Inc. | 1 | $19 |
| Elutia, Inc. | 1 | $18 |
| Inari Medical, Inc. | 1 | $18 |
| Cagent Vascular Inc | 1 | $17 |
| Angiodynamics, Inc. | 1 | $16 |
| Normatec Industries, LP | 1 | $16 |
| Cardiovascular Systems Inc. | 1 | $15 |
| Tactile Systems Technology Inc | 1 | $13 |
| Getinge USA Sales, LLC | 1 | $13 |
| Intact Vascular, Inc. | 1 | $13 |
| Cardiva Medical, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENROUTE Transcarotid Neuroprotection System$3,073
- ENHANCE Transcarotid Peripheral Access Kit$2,845
- AngioJet Ultra 5000A$2,178
- ENROUTE Transcarotid Stent$2,072
- ENROUTE .014 Guidewire$1,958
- Indigo System$1,897
- ENROUTE Transcarotid Stent System$887
- ENROUTE 0.014 Guidewire$887
- LIMFLOW SYSTEM$390
- TAG Thoracic Endoprosthesis$254
- Endurant$146
- Valiant Captivia$128
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$126
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$114
- Kerecis Omega3 Wound$110
- Kerecis Omega3 Surgibind$110
- Kerecis Omega3 GraftGuide$110
- Kerecis Omega3 SurgiClose$110
- GORE EXCLUDER Iliac Branch Endoprosthesis$110
How this compares
$12,528 in reported general payments places this provider in the 75th percentile of 119 vascular surgery providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cilostazol | 15 | $136 |
| ClopidogrelClopidogrel Bisulfate | 22 | $64 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Raleigh
- Robert MendesRaleigh$408K
- Ellen DillavouRaleigh$284K
- Christopher McQuinnRaleigh$77K
- Jason KimRaleigh$8K
- Kirk CharlesRaleigh$8K
- Liliana NanezRaleigh$7K
- Heather WaldropRaleigh$5K
- Jacek PaszkowiakRaleigh$4K
- James FogartieRaleigh$3K
- Frank ArkoCharlotte$2.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.